IOANA R BONTA
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ATLANTA, GA NPI 1306090659
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GA Novocure Inc. All categories
General Payments — all program years on this page
$44,074.42
- Category: General Payments
- Program years: PY2018–2024
- Record count: 314
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,864.65 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,600.00 | 1 |
| Consulting Fee | $1,272.50 | 2 |
| Food and Beverage | $966.07 | 42 |
| Education | $26.08 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novocure Inc. | $2,600.00 | 1 |
| Janssen Scientific Affairs, LLC | $817.50 | 1 |
| Daiichi Sankyo Inc. | $490.94 | 3 |
| PFIZER INC. | $280.51 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $133.56 | 5 |
| Acerta Pharma LLC | $89.77 | 4 |
| Celgene Corporation | $68.19 | 3 |
| Mirati Therapeutics, Inc. | $46.39 | 2 |
| Lilly USA, LLC | $35.47 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.84 | 1 |
| Tempus AI, Inc | $30.49 | 1 |
| Janssen Biotech, Inc. | $24.95 | 1 |
| Gilead Sciences, Inc. | $24.63 | 1 |
| GlaxoSmithKline, LLC. | $23.50 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $23.38 | 1 |
| EISAI INC. | $23.01 | 1 |
| Genentech USA, Inc. | $22.57 | 1 |
| Pharmacosmos Therapeutics Inc. | $21.71 | 1 |
| Legend Biotech USA Inc. | $21.45 | 1 |
| SOBI, INC | $19.52 | 1 |
| ABBVIE INC. | $19.29 | 1 |
| Karyopharm Therapeutics Inc. | $15.98 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.